Lilly Just Announced Infectious Disease Deals Diversification
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesEli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
A congressional hearing places federal fraud losses close to $1 trillion annually, far surpassing GAO estimates, as e...
Ripple is channeling billions into infrastructure to connect traditional finance with blockchain systems, reshaping t...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
A married pair earning $185,000 apiece can unlock about $94,000 in new Roth space in a single year by combining after...
A viral clash between a pop icon and political messaging reveals practical money lessons for everyday investors. Here...
Dividend-focused investors face a unique puzzle with Boeing: potential for future income vs. exposure to cyclic risk....
A Dallas mural of life-sized whales becomes the center of a $25 million lawsuit as World Cup organizers reportedly pa...
July 2026 market conditions put a premium on true readiness. This report outlines eight signs you’re financially read...
In a crowded crypto landscape, Ethereum still stands out for three core reasons. From its mature smart contract ecosy...
A 72-year-old widow faced threats that her Social Security could be garnished. The case highlights federal protection...
Fresh money data in 2026 contests one core debt strategy from Dave Ramsey, while underscoring the value of discipline...